Application | Comment | Organism |
---|---|---|
medicine | enzyme is a part of the pyrimidine biosynthesis pathway and plays a role as target for the chemotherapy of parasitic and neoplastic diseases | Faecalicatena orotica |
pharmacology | drug design based upon selective enzyme inhibition | Faecalicatena orotica |
General Stability | Organism |
---|---|
dithiothreitol stabilizes | Faecalicatena orotica |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(R,R)-5-benzyl-3-(1-carboxy-2-phenylethyl)hydantoin | - |
Faecalicatena orotica | |
(S)-5-benzyl-3-carboxymethylhydantoin | - |
Faecalicatena orotica | |
(S)-N-carboxymethyl-N'-(1-carboxy-2-phenylethyl)urea | - |
Faecalicatena orotica | |
(S,S)-5-benzyl-3-(1-carboxy-2-phenylethyl)hydantoin | - |
Faecalicatena orotica | |
(S,S)-N,N'-bis(1-carboxy-2-phenylethyl)urea | - |
Faecalicatena orotica | |
(S,S)-N-(1-carboxyethyl)-N'-(1-carboxy-2-phenylethyl)urea | 4 mM, 20% inhibition | Faecalicatena orotica | |
3-carboxymethylhydantoin | - |
Faecalicatena orotica | |
5-benzyl-3-(1-carboxy-2-phenylethyl)-1-methylhydantoin | - |
Faecalicatena orotica | |
5-Benzyl-3-(1-carboxy-2-phenylethyl)hydantoin | time-dependent irreversible inhibition at the active site, mechanism | Faecalicatena orotica | |
hydantoin | derived from alpha-amino acids, weak competitive inhibitors, compounds with a benzyl goup are better inhibitors | Faecalicatena orotica | |
isopropyl hydantoin | - |
Faecalicatena orotica | |
N,N'-bis(carboxymethyl)urea | - |
Faecalicatena orotica |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
dihydroorotate + NAD+ | Faecalicatena orotica | biosynthesis of pyrimidines | orotate + NADH + H+ | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Faecalicatena orotica | - |
identical with Clostridium oroticum | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
(S)-dihydroorotate + NAD+ | - |
Faecalicatena orotica | orotate + NADH + H+ | - |
? | |
dihydroorotate + NAD+ | biosynthesis of pyrimidines | Faecalicatena orotica | orotate + NADH + H+ | - |
? |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
25 | - |
assay at | Faecalicatena orotica |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
6.5 | - |
pH of assay medium | Faecalicatena orotica |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
flavin | flavoprotein with two different flavins, probably FAD and FMN | Faecalicatena orotica | |
flavin | NAD+-linked flavoprotein | Faecalicatena orotica |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.4 | - |
(S,S)-N,N'-bis(1-carboxy-2-phenylethyl)urea | - |
Faecalicatena orotica | |
0.6 | - |
5-benzyl-3-(1-carboxy-2-phenylethyl)-1-methylhydantoin | - |
Faecalicatena orotica | |
0.7 | - |
(S)-N-carboxymethyl-N'-(1-carboxy-2-phenylethyl)urea | - |
Faecalicatena orotica | |
0.7 | - |
(S,S)-5-benzyl-3-(1-carboxy-2-phenylethyl)hydantoin | - |
Faecalicatena orotica | |
0.9 | - |
(R,R)-5-benzyl-3-(1-carboxy-2-phenylethyl)hydantoin | - |
Faecalicatena orotica | |
2.3 | - |
(S)-5-benzyl-3-carboxymethylhydantoin | - |
Faecalicatena orotica | |
2.6 | - |
N,N'-bis(carboxymethyl)urea | - |
Faecalicatena orotica | |
4.5 | - |
3-carboxymethylhydantoin | - |
Faecalicatena orotica |